Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (29) Chen, Wei Prof. Dr. (3) Daniel, Peter Prof. Dr. (1) Escobar Fernandez, Helena Dr. (1) Fröhlich, Janine (1) Hübner, Norbert Prof. Dr. (2) Ivics, Zoltan Dr. (40) Izsvak, Zsuzsanna Dr. (40) Kammertöns, Thomas Dr. (7) Kieback, Elisa Dr. (2) Kopp, Joachim Dr. (2) Marg, Andreas Dr. (1) Nguyen, Tam Hoai Dr. (1) Prigione, Alessandro Prof. Dr. (1) Saar, Kathrin Dr. (1) Schlag, Peter M. Prof. Dr. (1) Singh, Manvendra Dr. (3) Spuler, Simone Prof. (1) Willimsky, Gerald Dr. (7) (-) Bunse, Mario Dr. (2) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Pezzutto, Antonio Prof. Dr. (3) (-) Uckert, Wolfgang Prof. Dr. (9) Bioinformatik der Genregulation (1) Entwicklung Mechanismus-basierter Krebstherapien (1) Experimentelle Ultrahochfeld-MR (7) Genetik metabolischer und reproduktiver Störungen (3) Genom-Editierung & Krankheitsmodelle (2) Genomics (1) Hochschulambulanz für Neuroimmunologie (1) Immunregulation und Krebs (3) Magnetic Resonance (7) (-) Mobile DNA (2) Molekulare Herz- Kreislaufforschung (1) (-) Molekulare Immunologie und Gentherapie (10) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (2) Translationale Onkologie solider Tumore (1) Zelluläre Neurowissenschaften (5) 1997 (2) 1998 (2) 1999 (1) 2000 (2) 2003 (4) (-) 2004 (2) 2005 (5) 2006 (1) 2007 (3) (-) 2008 (1) (-) 2010 (2) (-) 2011 (3) 2013 (1) 2014 (1) 2015 (3) (-) 2016 (4) 2017 (2) 2018 (3) 2019 (1) 2020 (2) 2021 (1) 2022 (3) 12 Ergebnisse: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Prof. Dr. rer. nat.Pezzutto, Antonio Prof. Dr.Uckert, Wolfgang Prof. Dr.Mobile DNAMolekulare Immunologie und Gentherapie 20042008201020112016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. März 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto 01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 01. März 2016 / Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. März 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
01. März 2016 / Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein